Search by Drug Name or NDC

NDC 11822-9902-06 Nicotine 2 mg/1 Details

Nicotine 2 mg/1

Nicotine is a ORAL LOZENGE in the HUMAN OTC DRUG category. It is labeled and distributed by Rite Aid Corporation. The primary component is NICOTINE.

MedlinePlus Drug Summary

Nicotine lozenges are used to help people stop smoking. Nicotine lozenges are in a class of medications called smoking cessation aids. They work by providing nicotine to your body to decrease the withdrawal symptoms experienced when smoking is stopped and to reduce the urge to smoke.

Related Packages: 11822-9902-06
Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Nicotine Lozenges

Product Information

NDC	11822-9902
Product ID	11822-9902_88ec5795-36c0-46f1-94d9-5611cdd5d6c7
Associated GPIs	79109903070303 79100070000320
GCN Sequence Number	n/a
GCN Sequence Number Description	n/a
HIC3	n/a
HIC3 Description	n/a
GCN	n/a
HICL Sequence Number	n/a
HICL Sequence Number Description	n/a
Brand/Generic	n/a
Proprietary Name	Nicotine
Proprietary Name Suffix	n/a
Non-Proprietary Name	nicotine polacrilex
Product Type	HUMAN OTC DRUG
Dosage Form	LOZENGE
Route	ORAL
Active Ingredient Strength	2
Active Ingredient Units	mg/1
Substance Name	NICOTINE
Labeler Name	Rite Aid Corporation
Pharmaceutical Class	Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]
DEA Schedule	n/a
Marketing Category	ANDA
Application Number	ANDA210711
Listing Certified Through	2024-12-31

Package

Package Images

NDC 11822-9902-06 (11822990206)

Pricing Information	N/A
NDC Package Code	11822-9902-6
Billing NDC	11822990206
Package	3 BOTTLE, PLASTIC in 1 BOX (11822-9902-6) / 27 LOZENGE in 1 BOTTLE, PLASTIC
Marketing Start Date	2020-07-30
NDC Exclude Flag	N

Standard Product Labeling (SPL)/Prescribing Information SPL d0c620e3-3cbf-45c8-abcb-28a2efa719db Details

Active ingredient (in each lozenge)

Nicotine polacrilex USP, 2 mg

Purpose

Stop smoking aid

Use

reduces withdrawal symptoms, including nicotine craving, associated with quitting smoking

Warnings

If you are pregnant or breast-feeding,

only use this medicine on the advice of your health care provider. Smoking can seriously harm your child. Try to stop smoking without using any nicotine replacement medicine. This medicine is believed to be safer than smoking. However, the risks to your child from this medicine are not fully known.

Ask a doctor before use if you have

heart disease, recent heart attack, or irregular heartbeat. Nicotine can increase your heart rate.
high blood pressure not controlled with medication. Nicotine can increase your blood pressure.
stomach ulcer or diabetes
history of seizures

Ask a doctor or pharmacist before use if you are

using a non-nicotine stop smoking drug
taking prescription medicine for depression or asthma. Your prescription dose may need to be adjusted.

Stop use and ask a doctor if

mouth problems occur
persistent indigestion or severe sore throat occurs
irregular heartbeat or palpitations occur
you get symptoms of nicotine overdose such as nausea, vomiting, dizziness, diarrhea, weakness and rapid heartbeat
you have symptoms of an allergic reaction (such as difficulty breathing or rash)

Keep out of reach of children and pets.

Nicotine lozenges may have enough nicotine to make children and pets sick. If you need to remove the lozenge, wrap it in paper and throw away in the trash. In case of overdose, get medical help or contact a Poison Control Center (1-800-222-1222) right away

Directions

if you are under 18 years of age, ask a doctor before use. No studies have been done to show if this product will work for you.
before using this product, read the enclosed User’s Guide for complete directions and other important information
begin using the lozenge on your quit day
if you smoke your first cigarette more than 30 minutes after waking up, use 2 mg nicotine lozenge
if you smoke your first cigarette within 30 minutes of waking up, use 4 mg nicotine lozenge according to the following 12 week schedule:

Weeks 1 to 6	Weeks 7 to 9	Weeks 10 to 12
1 lozenge every 1 to 2 hours	1 lozenge every 2 to 4 hours	1 lozenge every 4 to 8 hours

nicotine lozenge is a medicine and must be used a certain way to get the best results
place the lozenge in your mouth and allow the lozenge to slowly dissolve (about 20 to 30 minutes). Minimize swallowing. Do not chew or swallow lozenge.
you may feel a warm or tingling sensation
occasionally move the lozenge from one side of your mouth to the other until completely dissolved (about 20 to 30 minutes)
do not eat or drink 15 minutes before using or while the lozenge is in your mouth
to improve your chances of quitting, use at least 9 lozenges per day for the first 6 weeks
do not use more than one lozenge at a time or continuously use one lozenge after another since this may cause you hiccups, heartburn, nausea or other side effects
do not use more than 5 lozenges in 6 hours. Do not use more than 20 lozenges per day.
It is important to complete treatment. If you feel you need to use the lozenge for a longer period to keep from smoking, talk to your health care provider.

Other information

each lozenge contains: sodium 5 mg
store at 20º to 25ºC (68º to 77ºF)
keep bottle tightly closed and protect from light

Inactive ingredients

acesulfame potassium, colloidal silicon dioxide, cherry flavor, hydroxypropyl cellulose, magnesium stearate, mannitol, potassium bicarbonate, povidone, sodium alginate, sodium carbonate, sucralose,xanthan gum

Questions or comments?

Call 1-877-753-3935 Monday-Friday 9AM-5PM EST

Principal Display Panel

Compare to the active ingredient in Nicorette® mini Lozenge*

FREE | SUGAR

FROM | FREE

mini

Nicotine Lozenges

Nicotine Polacrilex Lozenge

Stop Smoking Aid

SUGAR FREE

2 mg

FOR THOSE WHO SMOKE THEIR FIRST CIGARETTE WITHIN 30 MINUTES OF WAKING UP.

If you smoke your first cigarette MORE THAN 30 MINUTES after waking up, use the 4 mg Nicotine Polacrilex Lozenge.

includes User's Guide

CHERRY FLAVOR

LOZENGES

TO INCREASE YOUR SUCCESS IN QUITTING:

1. You must be motivated to quit.

2. Use Enough - Use at least 9 Nicotine Polacrilex lozenges per day during the first six weeks.

3. Use Long Enough - Use Nicotine Polacrilex lozenges for the full 12 weeks.

4. Use With a Support Program as directed in the enclosed User's Guide.

not for sale to those under 18 years of age
proof of age required
not for sale in vending machines or from any source where proof of age cannot be verified

*This product is not affiliated, with manufactured by, or produced by the makers or owners of Nicorette® Lozenge.

TAMPER EVIDENT FEATURE: DO NOT USE IF PRINTED SEAL UNDER CAP IS BROKEN OR MISSING.

RETAIN OUTER CARTON FOR FULL PRODUCT USES, DIRECTIONS AND WARNINGS.

DISTRIBUTED BY:

RITE AID, 30 HUNTER LANE,

CAMP HILL. PA 17011

www.riteaid.com

Package Label

RITE AID Mini Nicotine Lozenges Cherry Flavor

INGREDIENTS AND APPEARANCE

NICOTINE

nicotine polacrilex lozenge

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC:11822-9902
Route of Administration	ORAL

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
NICOTINE (UNII: 6M3C89ZY6R) (NICOTINE - UNII:6M3C89ZY6R)	NICOTINE	2 mg

Ingredient Name	Strength
Inactive Ingredients
ACESULFAME POTASSIUM (UNII: 23OV73Q5G9)
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)
HYDROXYPROPYL CELLULOSE, UNSPECIFIED (UNII: 9XZ8H6N6OH)
MAGNESIUM STEARATE (UNII: 70097M6I30)
MANNITOL (UNII: 3OWL53L36A)
POTASSIUM BICARBONATE (UNII: HM5Z15LEBN)
POVIDONE (UNII: FZ989GH94E)
SODIUM ALGINATE (UNII: C269C4G2ZQ)
SODIUM CARBONATE (UNII: 45P3261C7T)
SUCRALOSE (UNII: 96K6UQ3ZD4)
XANTHAN GUM (UNII: TTV12P4NEE)

Product Characteristics
Color	white	Score	no score
Shape	ROUND	Size	10mm
Flavor	CHERRY	Imprint Code	A501
Contains

#	Item Code	Package Description	Marketing Start Date
Packaging
1	NDC:11822-9902-6	3 in 1 BOX	07/30/2020
1		27 in 1 BOTTLE, PLASTIC; Type 0: Not a Combination Product
2	NDC:11822-9902-8	1 in 1 BOX	07/30/2020
2		27 in 1 BOTTLE, PLASTIC; Type 0: Not a Combination Product

Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
Marketing Information
ANDA	ANDA210711	07/30/2020

Labeler - Rite Aid Corporation (014578892)

Revised: 1/2022

Document Id: 88ec5795-36c0-46f1-94d9-5611cdd5d6c7

Set id: d0c620e3-3cbf-45c8-abcb-28a2efa719db

Version: 3

Effective Time: 20220126